The Anti-IGFBP2 Antibody (M14) is a human monoclonal antibody that exhibits high-affinity binding to insulin-like growth factor-binding protein 2 (IGFBP2). This antibody effectively inhibits the interaction between IGFBP2 and insulin-like growth factor 1 (IGF1), thereby blocking IGFBP2's biological activity. The Anti-IGFBP2 Antibody (M14) has been demonstrated to inhibit endothelial cell recruitment, a critical process in tumor angiogenesis and metastasis, thereby impeding the progression of human metastatic cancers. This product is pivotal for research focused on cancer biology, particularly in studies exploring mechanisms of tumor growth and metastasis.
The Anti-IGFBP2 Antibody (M14) is a human monoclonal antibody that exhibits high-affinity binding to insulin-like growth factor-binding protein 2 (IGFBP2). This antibody effectively inhibits the interaction between IGFBP2 and insulin-like growth factor 1 (IGF1), thereby blocking IGFBP2's biological activity. The Anti-IGFBP2 Antibody (M14) has been demonstrated to inhibit endothelial cell recruitment, a critical process in tumor angiogenesis and metastasis, thereby impeding the progression of human metastatic cancers. This product is pivotal for research focused on cancer biology, particularly in studies exploring mechanisms of tumor growth and metastasis.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
